Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal.
Acta Oncol. 2017 Apr 07;:1-3
Authors: Lubberman FJ, van Erp NP, Ter Heine R, van Herpen CM
PMID: 28388255 [PubMed - as supplied by publisher]
http://ift.tt/2o9frYy
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου